Skip to main content

Table 5 Estimates of prevalence of high triglycerides levels and hypercholesterolemia among Iranian adults 25–64 years old

From: Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia

 

Triglycerides ≥ 150 mg/dl

Cholesterol ≥ 200 mg/dl

Cholesterol ≥ 240 mg/dl

 

National

estimatea

Prevalence

(95% CI)

National

estimatea

Prevalence

(95% CI)

National

estimatea

Prevalence

(95% CI)

Age

      

   25–34 (n = 843)

3.5

27.1 (23.7–30.7)

3.9

30.2 (26.8–33.7)

1.1

8.8 (6.6–11.6)

   35–44 (n = 902)

3.8

42.4 (37.4–47.7)

4.2

46.2 (42.5–50.0)

1.3

14.2 (11.4–17.6)

   45–54 (n = 869)

2.7

42.6 (39.3–45.9)

3.4

54.0 (50.3–57.7)

1.2

19.0 (16.6–21.6)

   55–64 (n = 783)

1.5

44.5 (40.7–48.4)

2.1

61.6 (56.3–66.6)

0.8

25.4 (21.7–29.5)

Sex

      

   Males (n = 1645)

6.3

39.6 (36.0–43.3)

6.4

40.4 (36.8–44.2)

1.8

11.0 (9.0–13.4)

   Females (n = 1752)

5.1

33.2 (30.3–36.2)

7.0

45.4 (42.1–48.7)

2.7

17.3 (15.1–19.8)

Residential area

      

   Urban (n = 2175)

8.8

39.3 (36.4–42.2)

9.9

44.2 (41.4–47.0)

3.2

14.4 (12.7–16.4)

   Rural (n = 1222)

2.6

29.3 (26.1–32.8)

3.5

39.6 (34.7–44.6)

1.2

13.4 (10.3–17.3)

Total national estimate

(n = 3397)

11.4

36.4 (34.1–38.9)

13.5

42.9 (40.4–45.4)

4.4

14.1 (12.6–15.9)

  1. CI: confidence interval
  2. a Rounded to the nearest million
  3. Estimates are weighted for age, sex, and residential area on the basis of the population of Iran in 2006 Iran